Concepedia

Brendan D. Galvin

BD

Statistics

Publications

11

Citations

1K

H-Index

10

Active since

1996

Affiliations

Massachusetts Institute of Technology(Current)

Howard Hughes Medical Institute

10X Genomics (United States)

New England Biolabs (United States)

Institute of Cancer Research

Brendan D. Galvin is an author at Massachusetts Institute of Technology specializing in life sciences, molecular biology, and genetics.

Publications per year

1996–2019

11

Publications

11

Resolving the full spectrum of human genome variation using Linked-Reads

Patrick Marks, Sarah Garcia, Álvaro Martínez Barrio et al. · Genome Research · 2019 · 313 citations · Full text

, , +17

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain

Scott C. Robertson, April N. Meyer, Kristen C. Hart et al. · Proceedings of the National Academy of Sciences · 1998 · 188 citations

, , +14

A High-Quality De novo Genome Assembly from a Single Mosquito Using PacBio Sequencing

Sarah B. Kingan, Haynes Heaton, Juliana Cudini et al. · Genes · 2019 · 154 citations · Full text

, , +17

Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Brendan D. Galvin, Kristen C. Hart, April N. Meyer et al. · Proceedings of the National Academy of Sciences · 1996 · 147 citations

, , +16

Six and Eya promote apoptosis through direct transcriptional activation of the proapoptotic BH3-only gene <i>egl-1</i> in <i>Caenorhabditis elegans</i>

Takashi Hirose, Brendan D. Galvin, H. Robert Horvitz · Proceedings of the National Academy of Sciences · 2010 · 51 citations · Full text

, , +17

1–5 of 11